Marc Schegerin
Director of Finance/CFO chez MORPHIC HOLDING, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Marc Schegerin is currently an Independent Director at SQZ Biotechnologies Co., Chief Financial & Operating Officer at Morphic Therapeutic, Inc., and Chief Operating & Financial Officer at Morphic Holding, Inc. Previously, he worked as a Program Director at Biogen, Inc. from 2009 to 2013, a Director at Citigroup, Inc. from 2016 to 2018, a Senior Director at SAGE Therapeutics, Inc. from 2013 to 2014, and as the Chief Financial Officer, Treasurer & Head-Strategy at ArQule, Inc. from 2019 to 2020.
He obtained his undergraduate degree from Tulane University (Louisiana), a doctorate from Dartmouth Medical School, an MBA from Tuck School of Business at Dartmouth, and another undergraduate degree from Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
0,07% | 16/01/2024 | 37 460 ( 0,07% ) | 1 M $ | 31/03/2024 |
| 31/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Marc Schegerin
| Sociétés | Poste | Début |
|---|---|---|
| MORPHIC HOLDING, INC. | Director of Finance/CFO | 06/04/2020 |
| SQZ BIOTECHNOLOGIES COMPANY | Director/Board Member | 23/10/2020 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director of Finance/CFO | 01/04/2020 |
Anciens postes connus de Marc Schegerin
| Sociétés | Poste | Fin |
|---|---|---|
| ARQULE, INC. | Director of Finance/CFO | 01/01/2020 |
| CITIGROUP INC. | Director/Board Member | 01/04/2018 |
| SAGE THERAPEUTICS, INC. | Director/Board Member | 01/01/2014 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2013 |
Formation de Marc Schegerin
| Harvard University | Undergraduate Degree |
| Tulane University (Louisiana) | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BIOGEN INC. | Health Technology |
| CITIGROUP INC. | Finance |
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
